Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

NCT00376896 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Colon
Irritable Bowel Syndrome (IBS)

Interventions

DRUG: GW876008 200mcg
DRUG: GW876008 20mcg
OTHER: Placebo

Sponsor

GlaxoSmithKline